Piperidinium,1-ethyl-1-[2-[(2-hydroxy-2,2-diphenylacetyl)oxy]ethyl]-, bromide (1:1) cas no:23182-46-9

NamePiperidinium,1-ethyl-1-[2-[(2-hydroxy-2,2-diphenylacetyl)oxy]ethyl]-, bromide (1:1)
CAS23182-46-9
SynonymsPiperidinium,1-ethyl-1-(2-hydroxyethyl)-, bromide, benzilate (8CI); Piperidinium,1-ethyl-1-[2-[(hydroxydiphenylacetyl)oxy]ethyl]-, bromide (9CI); Benzilic acid,ester with 1-ethyl-1-(2-hydroxyethyl)-piperidinium bromide (8CI); Benzilicacid, ester with 1-ethyl-1-(2-hydroxyethyl)piperidinium bromide (8CI);2-(1-Piperidino)ethylbenzilate ethylbromide
Molecular FormulaC23H30 N O3 . Br
Molecular Weight448.45

Safety

Poison by intramuscular, subcutaneous, intravenous, and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NO_x and Br⁻.

1.		orl-rat LD50:4600 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
2.		ipr-rat LD50:121 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
3.		scu-rat LD50:1350 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
4.		ivn-rat LD50:21 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
5.		ims-rat LD50:1570 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
6.		orl-mus LD50:1001 mg/kg		85IPAE    Modern Pharmaceuticals of Japan, V Tokyo, Japan.: Pharmaceutical, Medical and Dental Supply Exporters Association,1972,96.
7.		ipr-mus LD50:73 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
8.		scu-mus LD50:288 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),633.
9.